Concerns regarding SARS-CoV-2 JN.1 mutations should be raised
JN.1 is a new variant of SARS-CoV-2 which is a subvariant of Omicron (BA.2.86) was first discovered in the USA in September 2023. The virus’s capacity to spread and elude the immune system may be impacted by a single alteration in the spike protein, which serves as its distinguishing feature. JN.1 h...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2024
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/41715/ http://umpir.ump.edu.my/id/eprint/41715/1/The%20importance%20of%20in-silico%20studies%20in%20drug%20discovery.pdf |